Cited by 90Muscle Physiology and DisordersMitochondrial Function and PathologyChronic Obstructive Pulmonary Disease (COPD) Research

Skeletal Muscle Mitochondrial Dysfunction during Chronic Obstructive Pulmonary Disease: Central Actor and Therapeutic Target

Meyer, Alain, Zoll, Joffrey, Charles, Anne Laure, Charloux, Anne, de Blay, Frédéric, Diemunsch, Pierre, Sibilia, Jean, Piquard, François +1 more·2013·Experimental Physiology

Abstract

Muscle dysfunction is a common complication and an important prognostic factor in chronic obstructive pulmonary disease (COPD). As therapeutic strategies are still needed to treat this complication, gaining more insight into the process that leads to skeletal muscle decline in COPD appears to be an important issue. This review focuses on mitochondrial involvement in limb skeletal muscle alterations (decreased muscle mass, strength, endurance and power and increased fatigue) in COPD. Mitochondria are the main source of energy for the cells; they are involved in production of reactive oxygen species and activate an important pathway that leads to apoptosis. In COPD patients, skeletal muscles are characterized by decreased mitochondrial density and biogenesis, impaired activity and coupling of mitochondrial respiratory chain complexes, increased mitochondrial production of reactive oxygen species and, possibly, increased apoptosis. Of particular interest, a sedentary lifestyle, hypoxia, hypercapnia, tobacco smoking, corticosteroid therapy and, possibly, inflammation participate in this mitochondrial dysfunction, which is accessible to conventional therapies, such as exercise and tobacco cessation, as well as, potentially, to more innovative approaches, such as antioxidant treatment and supplementation with polyunsaturated fatty acids.

Integrity signals

Registry

Crossref · 10.1113/expphysiol.2012.069468

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Current knowledge considers that state 3 respiration (ADP-stimulated) is impaired in COPD patients; however, contradictory data are reported regarding complex I- or complex II-driven respiration states.

    “The current knowledge considers that state 3 respiration (ADP-stimulated) is impaired in COPD patients; however, contradictory data are reported regarding complex I- (CI) or complex II-, succinate dehydrogenase (CII-SDH), driven respiration states [100].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Meyer, A., Zoll, J., Charles, A. L., Charloux, A., de Blay, F., Diemunsch, P., Sibilia, J., Piquard, F., & Geny, B.
Affiliations
  • Hôpitaux Universitaires de Strasbourg (FR)
  • Université de Strasbourg (FR)
  • Hôpital d'Hautepierre (FR)
Corresponding author
Meyer, Alain
Venue
Experimental Physiology
Publisher
Wiley
Published
2013-03-08
Volume
98
Issue
6
Pages
1063-1078
ISSN
  • 0958-0670 (ISSN-L)
  • 1469-445X
OpenAlex
W2136598956
Cited by
90
References
13
Citations by year
2026: 6 · 2025: 6 · 2024: 3 · 2023: 7 · 2022: 4 · 2021: 2 · 2020: 7 · 2019: 12 · 2018: 3 · 2017: 5 · 2016: 12 · 2015: 8 · 2014: 11 · 2013: 4
FWCI
1.10
Type
journal article
Language
en
Open access
closed
Locations
  • Experimental Physiology (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
chronic obstructive pulmonary disease, skeletal muscle dysfunction, mitochondrial dysfunction, mitochondrial biogenesis, mitochondrial density, mitochondrial respiration, reactive oxygen species, mitochondrial apoptosis, vastus lateralis, muscle fatigue, exercise therapy, tobacco cessation, antioxidant treatment, polyunsaturated fatty acids, hypoxia, corticosteroid therapy, inflammation
MeSH terms
Animals, Humans, Mitochondria, Muscle, Muscle, Skeletal, Pulmonary Disease, Chronic Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review